Back to search
FDAFDA · Food and drugs·Recall number D-0262-2022

Ascorbic Acid Solution for Injection, 500 mg/mL, 50 mL Multiple Dose Vial, For IM, IV or SC Use Only, Rx only, ASP Cares, 2414 Babcock Rd Ste #106, San Antonio, TX 78229 NDC 72833-690-50

Published December 8, 2021 · Recall initiated: November 17, 2021

Summary

FDA records drug Class II recall D-0262-2022, published December 8, 2021 and initiated November 17, 2021. Recalling firm: ASP CARES; Status: Terminated; Reported quantity: 3077 vials; Lot: Lots: 092321690 BUD: 03/22/2022; 093021690 BUD: 03/29/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
ASP CARES
Distributor
United States
Lot
Lots: 092321690 BUD: 03/22/2022; 093021690 BUD: 03/29/2022
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Ascorbic Acid Solution for Injection, 500 mg/mL, 50 mL Multiple Dose Vial, For IM, IV or SC Use Only, Rx only, ASP Cares, 2414 Babcock Rd Ste #106, San Antonio, TX 78229 NDC 72833-690-50 recalled?

Yes. FDA published recall D-0262-2022 on December 8, 2021. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · Letter